Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc > Cash and Short-Term Investments

Rhythm Pharmaceuticals Inc Cash and Short-Term Investments Chart (RYTM)

Rhythm Pharmaceuticals Inc annual/quarterly Cash and Short-Term Investments from 2016 to 2018.
  • Rhythm Pharmaceuticals Inc Cash and Short-Term Investments for the quarter ending December 12, 2018 was $252m a 45.87% increase of 116m year over year
  • Rhythm Pharmaceuticals Inc Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $252m a 45.87% increase of 116m year over year
  • Rhythm Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2018 was $252m a 41.25% increase of 104m from 2017
  • Rhythm Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2017 was $148m a 92.88% increase of 138m from 2016
  • Rhythm Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2016 was $11m a -230.92% decrease of -24m from 2015
Other Balance Sheet Metrics:
  • Rhythm Pharmaceuticals Inc Total Assets for the quarter ending September 09, 2018 was $278m a 45.37% increase of 126m year over year
  • Rhythm Pharmaceuticals Inc Other Liabilities for the quarter ending September 09, 2018 was $0m a 20.83% increase of 0m year over year
  • Rhythm Pharmaceuticals Inc Total Equity for the quarter ending September 09, 2018 was $270m a 46.30% increase of 125m year over year
View Chart On Koyfin

Quarterly RYTM Cash and Short-Term Investments Data

12/2018$252m
09/2018$272m
06/2018$288m
03/2018$136m
12/2017$148m
09/2017$30m
06/2017$18m
03/2017$24m
12/2016$11m

Annual RYTM Cash and Short-Term Investments Data

2018$252m
2017$148m
2016$11m
2015$35m